{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:39:46Z","timestamp":1771670386826,"version":"3.50.1"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bcp.2021.114746","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T03:05:44Z","timestamp":1630033544000},"page":"114746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Modeling genetic cardiac channelopathies using induced pluripotent stem cells \u2013 Status quo from an electrophysiological perspective"],"prefix":"10.1016","volume":"192","author":[{"given":"Michelle Vanessa Kapchoup","family":"Kamga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Reppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Hescheler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomain","family":"Nguemo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114746_b0005","doi-asserted-by":"crossref","unstructured":"W. Hinton, A. McGovern, R. Coyle, T.S. Han, P. Sharma, A. Correa, F. Ferreira, S. de Lusignan, Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC), BMJ Open 8(8) (2018) e020282-e020282.","DOI":"10.1136\/bmjopen-2017-020282"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/CIRCGENETICS.108.836478","article-title":"Multiple mutations in genetic cardiovascular disease: a marker of disease severity?","volume":"2","author":"Kelly","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003631","article-title":"Relationship between arrhythmogenic right ventricular cardiomyopathy and brugada syndrome: new insights from molecular biology and clinical implications","volume":"9","author":"Corrado","year":"2016","journal-title":"Circ Arrhythm. Electrophysiol."},{"issue":"18","key":"10.1016\/j.bcp.2021.114746_b0020","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the congenital long-QT syndrome","volume":"120","author":"Schwartz","year":"2009","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12170-019-0612-2","article-title":"Prevalence, clinical presentation, and management of channelopathies and cardiomyopathies, long QT syndrome, brugada syndrome, arrhythmogenic cardiomyopathy, and hypertrophic cardiomyopathy","volume":"13","author":"Haugaa","year":"2019","journal-title":"urr. Cardiovasc. Risk Rep."},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41569-019-0266-2","article-title":"Epidemiology of inherited arrhythmias","volume":"17","author":"Offerhaus","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bcp.2021.114746_b0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fcvm.2018.00137","article-title":"Disease Modifiers of Inherited SCN5A Channelopathy","volume":"5","author":"Verkerk","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bcp.2021.114746_b0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcvm.2016.00009","article-title":"The brugada syndrome: a rare arrhythmia disorder with complex inheritance","volume":"3","author":"Gourraud","year":"2016","journal-title":"Front. Cardiovasc. Med."},{"issue":"12","key":"10.1016\/j.bcp.2021.114746_b0045","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.RES.85.12.1206","article-title":"A single Na(+) channel mutation causing both long-QT and Brugada syndromes","volume":"85","author":"Bezzina","year":"1999","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.bcp.2021.114746_b0050","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ccr3.1064","article-title":"Double jeopardy: long QT3 and Brugada syndromes","volume":"5","author":"Sandhu","year":"2017","journal-title":"Clin. Case Rep."},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/heartjnl-2012-302033","article-title":"Catecholaminergic polymorphic ventricular tachycardia: from bench to bedside","volume":"99","author":"van der Werf","year":"2013","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0060","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jtbi.2008.04.027","article-title":"A calcium-induced calcium release mechanism mediated by calsequestrin","volume":"253","author":"Lee","year":"2008","journal-title":"J. Theor. Biol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0065","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1540-8167.2007.00766.x","article-title":"Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia","volume":"18","author":"Mohamed","year":"2007","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/joa3.12053","article-title":"Three cases of catecholaminergic polymorphic ventricular tachycardia with prolonged QT intervals including two cases of compound mutations","volume":"34","author":"Saito","year":"2018","journal-title":"Journal of Arrhythmia"},{"issue":"23","key":"10.1016\/j.bcp.2021.114746_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238893","article-title":"hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery","volume":"21","author":"Li","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0080","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/cpmb.58","article-title":"Human induced pluripotent stem cell production and expansion from blood using a non-integrating viral reprogramming vector","volume":"122","author":"Sharma","year":"2018","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.bcp.2021.114746_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-015-0112-3","article-title":"Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP\/EBNA-1 episomal reprogramming system","volume":"6","author":"Drozd","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bcp.2021.114746_b0095","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4370","article-title":"Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications","volume":"6","author":"Omole","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.bcp.2021.114746_b0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijcard.2017.03.099","article-title":"Making human cardiomyocytes up to date: Derivation, maturation state and perspectives","volume":"241","author":"Kolanowski","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"24","key":"10.1016\/j.bcp.2021.114746_b0105","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.7150\/thno.32058","article-title":"Generation of human induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer and scalable 3D suspension bioreactor cultures with reduced batch-to-batch variations","volume":"9","author":"Hamad","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1159\/000335753","article-title":"In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells","volume":"28","author":"Fatima","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"issue":"12","key":"10.1016\/j.bcp.2021.114746_b0115","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99941","article-title":"Deep phenotyping of human induced pluripotent stem cell\u2013derived atrial and ventricular cardiomyocytes","volume":"3","author":"Cyganek","year":"2018","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nmeth.3448","article-title":"Chemically defined, albumin-free human cardiomyocyte generation","volume":"12","author":"Lian","year":"2015","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.bcp.2021.114746_b0125","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nat. Methods"},{"issue":"7700","key":"10.1016\/j.bcp.2021.114746_b0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","article-title":"Advanced maturation of human cardiac tissue grown from pluripotent stem cells","volume":"556","author":"Ronaldson-Bouchard","year":"2018","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2021.114746_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223424","article-title":"Correction: Maturation of three-dimensional, hiPSC-derived cardiomyocyte spheroids utilizing cyclic, uniaxial stretch and electrical stimulation","volume":"14","author":"LaBarge","year":"2019","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.bcp.2021.114746_b0140","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.ymthe.2018.08.012","article-title":"Maturation of human induced pluripotent stem cell-derived cardiomyocytes by soluble factors from human mesenchymal stem cells","volume":"26","author":"Yoshida","year":"2018","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0145","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/0963689718779346","article-title":"The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin","volume":"27","author":"Lewandowski","year":"2018","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bcp.2021.114746_b0150","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/508294","article-title":"Effects of substrate mechanics on contractility of cardiomyocytes generated from human pluripotent stem cells","volume":"2012","author":"Hazeltine","year":"2012","journal-title":"Int. J. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0155","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.stemcr.2021.01.018","article-title":"Maturation of pluripotent stem cell-derived cardiomyocytes enables modeling of human hypertrophic cardiomyopathy","volume":"16","author":"Knight","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"12","key":"10.1016\/j.bcp.2021.114746_b0160","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.117.311920","article-title":"Thyroid and glucocorticoid hormones promote functional T-tubule development in human-induced pluripotent stem cell-derived cardiomyocytes","volume":"121","author":"Parikh","year":"2017","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0165","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.stemcr.2019.08.013","article-title":"Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells","volume":"13","author":"Yang","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"12","key":"10.1016\/j.bcp.2021.114746_b0170","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.celrep.2015.08.042","article-title":"Defined MicroRNAs induce aspects of maturation in mouse and human embryonic-stem-cell-derived cardiomyocytes","volume":"12","author":"Lee","year":"2015","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCRESAHA.118.311209","article-title":"Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists","volume":"123","author":"Garg","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2021.114746_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2019.04.002","article-title":"Functional properties of engineered heart slices incorporating human induced pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Blazeski","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0185","doi-asserted-by":"crossref","first-page":"13834","DOI":"10.1038\/s41598-017-13590-y","article-title":"hiPSC-CM monolayer maturation state determines drug responsiveness in high throughput pro-arrhythmia screen","volume":"7","author":"da Rocha","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2021.114746_b0190","first-page":"80","article-title":"Structural Immaturity of Human iPSC-Derived Cardiomyocytes","volume":"9","author":"Koivumaki","year":"2018","journal-title":"Silico Investigation of Effects on Function and Disease Modeling, Front Physiol"},{"issue":"25","key":"10.1016\/j.bcp.2021.114746_b0195","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1161\/CIRCULATIONAHA.111.066092","article-title":"Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease","volume":"125","author":"Davis","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bcp.2021.114746_b0200","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1161\/RES.0000000000000291","article-title":"Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association","volume":"125","author":"Gintant","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2021.114746_b0205","doi-asserted-by":"crossref","unstructured":"Z. Zhao, H. Lan, I. El-Battrawy, X. Li, F. Buljubasic, K. Sattler, G. Y\u00fccel, S. Lang, M. Tiburcy, W.-H. Zimmermann, L. Cyganek, J. Utikal, T. Wieland, M. Borggrefe, X.-B. Zhou, I. Akin, Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Stem Cells Int 2018 (2018) 6067096-6067096.","DOI":"10.1155\/2018\/6067096"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0210","first-page":"269","article-title":"Biophysical, Molecular, and Pharmacological Characterization of Voltage-Dependent Sodium Channels From Induced Pluripotent Stem Cell-Derived Cardiomyocytes","volume":"33","author":"Moreau","year":"2017","journal-title":"Can. J. Cardiol."},{"issue":"24","key":"10.1016\/j.bcp.2021.114746_b0215","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2174\/138161209788923804","article-title":"Cardiac applications for human pluripotent stem cells","volume":"15","author":"Shiba","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020657","article-title":"The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases","volume":"21","author":"Pourrier","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2021.114746_b0225","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.bbamcr.2015.12.013","article-title":"Methods for in vitro functional analysis of iPSC derived cardiomyocytes - Special focus on analyzing the mechanical beating behavior","author":"Laurila","year":"2016","journal-title":"Biochim Biophys Acta 1863(7 Pt B)"},{"key":"10.1016\/j.bcp.2021.114746_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2019.05.028","article-title":"A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM)","volume":"7","author":"House","year":"2020","journal-title":"MethodsX"},{"key":"10.1016\/j.bcp.2021.114746_b0235","series-title":"Advances in Network Electrophysiology: Using Multi-Electrode Arrays","first-page":"38","article-title":"Multi-Electrode Arrays: Enhancing Traditional Methods and Enabling Network Physiology","author":"Whitson","year":"2006"},{"issue":"6","key":"10.1016\/j.bcp.2021.114746_b0240","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/19336950.2015.1079675","article-title":"Novel screening techniques for ion channel targeting drugs","volume":"9","author":"Obergrussberger","year":"2015","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.bcp.2021.114746_b0245","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.toxrep.2020.02.002","article-title":"Real-time cell analysis system in cytotoxicity applications: Usefulness and comparison with tetrazolium salt assays","volume":"7","author":"Stefanowicz-Hajduk","year":"2020","journal-title":"Toxicol. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2021.114746_b0250","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.hrthm.2019.12.020","article-title":"Improving long QT syndrome diagnosis by a polynomial-based T-wave morphology characterization","volume":"17","author":"Hermans","year":"2020","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0255","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00246-019-02151-x","article-title":"Long QT Syndrome: Genetics and Future Perspective","volume":"40","author":"Wallace","year":"2019","journal-title":"Pediatr. Cardiol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0260","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.002480","article-title":"Calcium Revisited: New Insights Into the Molecular Basis of Long-QT Syndrome, Circulation","volume":"9","author":"Giudicessi","year":"2016","journal-title":"Arrhythmia and electrophysiology"},{"key":"10.1016\/j.bcp.2021.114746_b0265","doi-asserted-by":"crossref","unstructured":"A.R. Perez-Riera, R. Barbosa-Barros, R. Daminello Raimundo, M.P. da Costa de Rezende Barbosa, I.C. Esposito Sorpreso, L.C. de Abreu, The congenital long QT syndrome Type 3: An update, Indian Pacing Electrophysiol J 18(1) (2018) 25-35.","DOI":"10.1016\/j.ipej.2017.10.011"},{"issue":"22","key":"10.1016\/j.bcp.2021.114746_b0270","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.jacc.2009.09.016","article-title":"Genotype-phenotype relationship in the long QT syndrome: brimming with knowledge but thirsting for a therapeutic solution","volume":"54","author":"Nademanee","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0275","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jacep.2016.10.013","article-title":"T-Wave Morphology Analysis in Congenital Long QT Syndrome Discriminates Patients From Healthy Individuals","volume":"3","author":"Porta-Sanchez","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ipej.2016.03.003","article-title":"Phenotype guided characterization and molecular analysis of Indian patients with long QT syndromes","volume":"16","author":"Vyas","year":"2016","journal-title":"Indian pacing and electrophysiology journal"},{"issue":"11","key":"10.1016\/j.bcp.2021.114746_b0285","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.hrthm.2015.06.040","article-title":"Diagnostic value of T-wave morphology changes during \u201cQT stretching\u201d in patients with long QT syndrome","volume":"12","author":"Chorin","year":"2015","journal-title":"Heart rhythm"},{"issue":"10","key":"10.1016\/j.bcp.2021.114746_b0290","first-page":"861","article-title":"Heterogeneous Phenotype of Long QT Syndrome Caused by the KCNH2-H562R Mutation: Importance of Familial Genetic Testing","volume":"68","author":"Munoz-Esparza","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5339\/gcsp.2015.26","article-title":"Genotype-phenotype correlation in long QT syndrome","volume":"2015","author":"Baskar","year":"2015","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.bcp.2021.114746_b0300","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3389\/fphys.2018.01127","article-title":"Gender Differences in Prognosis and Risk Stratification of Brugada Syndrome: A Pooled Analysis of 4,140 Patients From 24 Clinical Trials","volume":"9","author":"Yuan","year":"2018","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0305","first-page":"267","article-title":"Worldwide Prevalence of Brugada Syndrome: A Systematic Review and Meta-Analysis","volume":"34","author":"Vutthikraivit","year":"2018","journal-title":"Acta Cardiol Sin"},{"issue":"40","key":"10.1016\/j.bcp.2021.114746_b0310","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1093\/eurheartj\/ehx490","article-title":"The definition of the Brugada syndrome","volume":"38","author":"Sieira","year":"2017","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0315","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.hrthm.2009.09.069","article-title":"An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing","volume":"7","author":"Kapplinger","year":"2010","journal-title":"Heart rhythm : the official journal of the Heart Rhythm Society"},{"issue":"10","key":"10.1016\/j.bcp.2021.114746_b0320","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.hrthm.2018.06.019","article-title":"Gender differences in patients with Brugada syndrome and arrhythmic events: Data from a survey on arrhythmic events in 678 patients","volume":"15","author":"Milman","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.bcp.2021.114746_b0325","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3389\/fgene.2019.00547","article-title":"Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype","volume":"10","author":"Micaglio","year":"2019","journal-title":"Front. Genet."},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0330","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003379","article-title":"Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect","volume":"5","author":"Veltmann","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.bcp.2021.114746_b0335","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14779072.2018.1475230","article-title":"Recent advances in the treatment of Brugada syndrome","volume":"16","author":"Argenziano","year":"2018","journal-title":"Expert review of cardiovascular therapy"},{"issue":"15","key":"10.1016\/j.bcp.2021.114746_b0340","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jacc.2018.03.005","article-title":"Programmed Ventricular Stimulation and Brugada Syndrome: New Insights, Old Controversies","volume":"71","author":"Wilber","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2021.114746_b0345","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fcvm.2018.00132","article-title":"Higher Dispersion Measures of Conduction and Repolarization in Type 1 Compared to Non-type 1 Brugada Syndrome Patients: An Electrocardiographic Study From a Single Center","volume":"5","author":"Tse","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0350","doi-asserted-by":"crossref","first-page":"C576","DOI":"10.1152\/ajpcell.00028.2019","article-title":"Autonomic modulation of the electrical substrate in mice haploinsufficient for cardiac sodium channels: a model of the Brugada syndrome","volume":"317","author":"Finlay","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0355","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","article-title":"Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death","volume":"115","author":"Antzelevitch","year":"2007","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.bcp.2021.114746_b0360","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/01.CIR.0000034169.45752.4A","article-title":"Proposed Diagnostic Criteria for the Brugada Syndrome","volume":"106","author":"Wilde","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0365","first-page":"1095","volume":"18","author":"Gottschalk","year":"2016","journal-title":"Cardiology"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0370","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacc.2005.03.066","article-title":"Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood","volume":"46","author":"Beaufort-Krol","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0375","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/01.CIR.74.2.340","article-title":"Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval","volume":"74","author":"Nguyen","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2021.114746_b0380","unstructured":"C. Napolitano, S.G. Priori, R. Bloise, Catecholaminergic Polymorphic Ventricular Tachycardia, in: M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, K. Stephens, A. Amemiya (Eds.), GeneReviews((R)), Seattle (WA), 1993."},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0385","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yjmcc.2008.10.012","article-title":"Ryanodine receptor and calsequestrin in arrhythmogenesis: what we have learnt from genetic diseases and transgenic mice","volume":"46","author":"Liu","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114746_b0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205925","article-title":"Catecholaminergic polymorphic ventricular tachycardia patients with multiple genetic variants in the PACES CPVT Registry","volume":"13","author":"Roston","year":"2018","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bcp.2021.114746_b0395","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.joa.2015.09.008","article-title":"Current topics in catecholaminergic polymorphic ventricular tachycardia","volume":"32","author":"Sumitomo","year":"2016","journal-title":"Journal of arrhythmia"},{"key":"10.1016\/j.bcp.2021.114746_b0400","doi-asserted-by":"crossref","DOI":"10.1007\/s00424-016-1844-3","article-title":"Electrophysiological characterization of a large set of novel variants in the SCN5A-gene: identification of novel LQTS3 and BrS mutations","volume":"468","author":"Ortiz-Bonnin","year":"2016","journal-title":"Pfl\u00fcgers Arch. Eur. J. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0405","first-page":"280","article-title":"Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology","volume":"9","author":"Khan","year":"2004","journal-title":"Inc"},{"issue":"9","key":"10.1016\/j.bcp.2021.114746_b0410","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.CIR.102.9.945","article-title":"The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge","volume":"102","author":"Priori","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0415","first-page":"253","article-title":"[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?], Italian heart journal","volume":"2","author":"Cerrone","year":"2001","journal-title":"Supplement : official journal of the Italian Federation of Cardiology"},{"issue":"6","key":"10.1016\/j.bcp.2021.114746_b0420","first-page":"2219","article-title":"The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome","volume":"118","author":"Makita","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2021.114746_b0425","doi-asserted-by":"crossref","unstructured":"M. Mantegazza, W.A. Catterall, Voltage-Gated Na(+) Channels: Structure, Function, and Pathophysiology, in: th, J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (Eds.), Jasper's Basic Mechanisms of the Epilepsies, Bethesda (MD), 2012.","DOI":"10.1093\/med\/9780199746545.003.0004"},{"issue":"Pt 3","key":"10.1016\/j.bcp.2021.114746_b0430","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1469-7793.1998.647bp.x","article-title":"Structure and function of voltage-gated sodium channels","volume":"508","author":"Marban","year":"1998","journal-title":"The Journal of physiology"},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0435","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/gb-2003-4-3-207","article-title":"Overview of the voltage-gated sodium channel family","volume":"4","author":"Yu","year":"2003","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0440","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1113\/expphysiol.2013.071969","article-title":"Structure and function of voltage-gated sodium channels at atomic resolution","volume":"99","author":"Catterall","year":"2014","journal-title":"Exp. Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114746_b0445","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nchembio.2353","article-title":"The chemical basis for electrical signaling","volume":"13","author":"Catterall","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"18","key":"10.1016\/j.bcp.2021.114746_b0450","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1021\/jm501981g","article-title":"Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications","volume":"58","author":"de Lera Ruiz","year":"2015","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0455","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/geno.1996.0236","article-title":"Genomic organization of the human SCN5A gene encoding the cardiac sodium channel","volume":"34","author":"Wang","year":"1996","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0460","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/cvw234","article-title":"Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia\/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis","volume":"113","author":"Te Riele","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0465","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jama.293.4.447","article-title":"Sodium channel mutations and susceptibility to heart failure and atrial fibrillation","volume":"293","author":"Olson","year":"2005","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0470","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.hrthm.2012.02.023","article-title":"Genetic variants in SCN5A promoter are associated with arrhythmia phenotype severity in patients with heterozygous loss-of-function mutation","volume":"9","author":"Park","year":"2012","journal-title":"Heart rhythm"},{"issue":"11","key":"10.1016\/j.bcp.2021.114746_b0475","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003996","article-title":"Ryanodine receptors: structure, expression, molecular details, and function in calcium release","volume":"2","author":"Lanner","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.bcp.2021.114746_b0480","first-page":"d970","article-title":"Ryanodine receptors, FKBP12, and heart failure","volume":"7","author":"Marks","year":"2002","journal-title":"Frontiers in bioscience : a journal and virtual library"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0485","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.cardiores.2004.01.016","article-title":"Incorporation of connexins into plasma membranes and gap junctions","volume":"62","author":"Martin","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0490","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00424-010-0794-4","article-title":"Ryanodine receptor channelopathies","volume":"460","author":"Betzenhauser","year":"2010","journal-title":"Pflugers Arch."},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0495","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00220765","article-title":"Appraisal of the physiological relevance of two hypothesis for the mechanism of calcium release from the mammalian cardiac sarcoplasmic reticulum: calcium-induced release versus charge-coupled release","volume":"89","author":"Fabiato","year":"1989","journal-title":"Mol. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.bcp.2021.114746_b0500","first-page":"2425","article-title":"Alterations in ryanodine receptors and related proteins in heart failure","volume":"1832","author":"Ather","year":"2013","journal-title":"BBA"},{"issue":"12","key":"10.1016\/j.bcp.2021.114746_b0505","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1093\/emboj\/17.12.3309","article-title":"Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2","volume":"17","author":"Takeshima","year":"1998","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.bcp.2021.114746_b0510","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.RES.0000091335.07574.86","article-title":"Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes","volume":"93","author":"George","year":"2003","journal-title":"Circ. Res."},{"issue":"25","key":"10.1016\/j.bcp.2021.114746_b0515","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1161\/CIRCULATIONAHA.104.507921","article-title":"Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure","volume":"111","author":"Oda","year":"2005","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.bcp.2021.114746_b0520","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1085\/jgp.201711878","article-title":"The structural basis of ryanodine receptor ion channel function","volume":"149","author":"Meissner","year":"2017","journal-title":"The Journal of general physiology"},{"issue":"6","key":"10.1016\/j.bcp.2021.114746_b0525","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jacbts.2017.06.008","article-title":"Suppression of Arrhythmia by Enhancing Mitochondrial Ca(2+) Uptake in Catecholaminergic Ventricular Tachycardia Models","volume":"2","author":"Schweitzer","year":"2017","journal-title":"JACC. Basic to translational science"},{"issue":"12","key":"10.1016\/j.bcp.2021.114746_b0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083005","article-title":"The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients","volume":"8","author":"Fatima","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0535","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1085\/jgp.201210899","article-title":"Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics","volume":"141","author":"Terrenoire","year":"2013","journal-title":"The Journal of general physiology"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0540","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00395-016-0530-0","article-title":"Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction","volume":"111","author":"Malan","year":"2016","journal-title":"Basic Res. Cardiol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114746_b0545","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1016\/j.ijcard.2013.08.015","article-title":"Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells","volume":"168","author":"Ma","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0550","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.hrthm.2010.11.034","article-title":"A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations","volume":"8","author":"Shinlapawittayatorn","year":"2011","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0555","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0008-6363(02)00265-1","article-title":"Rate-dependent QT shortening mechanism for the LQT3 deltaKPQ mutant","volume":"54","author":"Nagatomo","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2021.114746_b0560","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1440-1681.12721","article-title":"Ion channels, long QT syndrome and arrhythmogenesis in ageing","volume":"44","author":"Jeevaratnam","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114746_b0565","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1172\/JCI0215928","article-title":"Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome","volume":"110","author":"Clancy","year":"2002","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.bcp.2021.114746_b0570","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/01.RES.0000069689.09869.A8","article-title":"Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families","volume":"92","author":"Veldkamp","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2021.114746_b0575","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fcvm.2018.00106","article-title":"Long QT Syndrome and Sinus Bradycardia-A Mini Review","volume":"5","author":"Wilders","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.bcp.2021.114746_b0580","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.hrthm.2017.07.026","article-title":"Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach","volume":"14","author":"Paci","year":"2017","journal-title":"Heart rhythm"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0585","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.stemcr.2014.06.003","article-title":"Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia","volume":"3","author":"Spencer","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bcp.2021.114746_b0590","first-page":"19","article-title":"Distinct electrophysiological and mechanical beating phenotypes of long QT syndrome type 1-specific cardiomyocytes carrying different mutations","volume":"8","author":"Kiviaho","year":"2015","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"9","key":"10.1016\/j.bcp.2021.114746_b0595","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/hmg\/ddx073","article-title":"Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation","volume":"26","author":"Yamamoto","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2021.114746_b0600","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yjmcc.2017.10.002","article-title":"Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient","volume":"114","author":"Selga","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"19","key":"10.1016\/j.bcp.2021.114746_b0605","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2016.07.779","article-title":"Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome","volume":"68","author":"Liang","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2021.114746_b0610","first-page":"467","article-title":"Electrophysiological Mechanisms of Brugada Syndrome: Insights from Pre-clinical and Clinical Studies","volume":"7","author":"Tse","year":"2016","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0615","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCEP.110.959619","article-title":"KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation","volume":"4","author":"Ohno","year":"2011","journal-title":"Circ Arrhythm. Electrophysiol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0620","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.hrthm.2011.02.021","article-title":"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome","volume":"8","author":"Giudicessi","year":"2011","journal-title":"Heart rhythm"},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0625","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/cvr\/cvn274","article-title":"Intracellular calcium modulation of voltage-gated sodium channels in ventricular myocytes","volume":"81","author":"Casini","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0630","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/19336950.2015.1075677","article-title":"Calmodulin and Ca(2+) control of voltage gated Na(+) channels","volume":"10","author":"Gabelli","year":"2016","journal-title":"Channels"},{"key":"10.1016\/j.bcp.2021.114746_b0635","doi-asserted-by":"crossref","unstructured":"C.N. Johnson, F. Potet, M.K. Thompson, B.M. Kroncke, A.M. Glazer, M.W. Voehler, B.C. Knollmann, A.L. George, Jr., W.J. Chazin, A Mechanism of Calmodulin Modulation of the Human Cardiac Sodium Channel, Structure 26(5) (2018) 683-694 e3.","DOI":"10.1016\/j.str.2018.03.005"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0640","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCGENETICS.113.000292","article-title":"Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations","volume":"7","author":"Hoshi","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0645","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jjcc.2015.08.009","article-title":"Brugada syndrome: More than 20 years of scientific excitement","volume":"67","author":"Brugada","year":"2016","journal-title":"J. Cardiol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114746_b0650","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004195","article-title":"Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? All High-Risk Patients Should Receive an Implantable Cardiac Defibrillator, Circulation","volume":"9","author":"Sieira","year":"2016","journal-title":"Arrhythmia and electrophysiology"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0655","first-page":"82","article-title":"The Brugada Syndrome - Diagnosis","volume":"9","author":"Batchvarov","year":"2014","journal-title":"Clinical Implications and Risk Stratification, Eur Cardiol"},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0660","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.hrthm.2006.10.026","article-title":"Abnormal expression of cardiac neural crest cells in heart development: a different hypothesis for the etiopathogenesis of Brugada syndrome","volume":"4","author":"Elizari","year":"2007","journal-title":"Heart rhythm"},{"issue":"6","key":"10.1016\/j.bcp.2021.114746_b0665","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1083\/jcb.143.6.1725","article-title":"Gap junction-mediated cell-cell communication modulates mouse neural crest migration","volume":"143","author":"Huang","year":"1998","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0670","doi-asserted-by":"crossref","first-page":"H279","DOI":"10.1152\/ajpheart.00079.2010","article-title":"Ionic mechanisms of cellular electrical and mechanical abnormalities in Brugada syndrome, American journal of physiology","volume":"300","author":"Dong","year":"2011","journal-title":"Heart and circulatory physiology"},{"issue":"10","key":"10.1016\/j.bcp.2021.114746_b0675","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.jacc.2005.12.064","article-title":"Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study","volume":"47","author":"Aiba","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0680","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.yjmcc.2010.07.012","article-title":"The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization","volume":"49","author":"Wilde","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2021.114746_b0685","doi-asserted-by":"crossref","first-page":"30967","DOI":"10.1038\/srep30967","article-title":"hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities","volume":"6","author":"Veerman","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bcp.2021.114746_b0690","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1161\/01.RES.0000169067.51055.72","article-title":"Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor","volume":"96","author":"Cerrone","year":"2005","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0695","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.RES.0000235869.50747.e1","article-title":"Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model","volume":"99","author":"Liu","year":"2006","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0700","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia","volume":"103","author":"Priori","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2021.114746_b0705","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2018.02.014","article-title":"Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2","volume":"117","author":"Xiong","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"13","key":"10.1016\/j.bcp.2021.114746_b0710","doi-asserted-by":"crossref","first-page":"E1669","DOI":"10.1073\/pnas.1419795112","article-title":"Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function","volume":"112","author":"Zhao","year":"2015","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0715","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.hrthm.2016.10.015","article-title":"A type 2 ryanodine receptor variant associated with reduced Ca(2+) release and short-coupled torsades de pointes ventricular arrhythmia","volume":"14","author":"Fujii","year":"2017","journal-title":"Heart rhythm"},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0720","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.humpath.2005.04.019","article-title":"Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates","volume":"36","author":"d'Amati","year":"2005","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0725","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1540-8167.2003.02545.x","article-title":"Implantable cardioverter defibrillator in high-risk long QT syndrome patients","volume":"14","author":"Zareba","year":"2003","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114746_b0730","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jacc.2015.12.030","article-title":"Gene-Specific Therapy for Congenital Long QT Syndrome: Are We There Yet?","volume":"67","author":"Arbelo","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114746_b0735","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIRCEP.115.002760","article-title":"Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels","volume":"8","author":"Potet","year":"2015","journal-title":"Circ Arrhythm. Electrophysiol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114746_b0740","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/clc.23247","article-title":"Implantable cardioverter-defibrillator in Brugada syndrome: Long-term follow-up","volume":"42","author":"El-Battrawy","year":"2019","journal-title":"Clin. Cardiol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0745","doi-asserted-by":"crossref","first-page":"135","DOI":"10.15420\/aer.2018.21.2","article-title":"Pharmacological Therapy in Brugada Syndrome","volume":"7","author":"Brodie","year":"2018","journal-title":"Arrhythmia Electrophysiol. Rev."},{"key":"10.1016\/j.bcp.2021.114746_b0750","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3389\/fphar.2019.01374","article-title":"Pharmacological Profile of the Sodium Current in Human Stem Cell-Derived Cardiomyocytes Compares to Heterologous Nav1.5+beta1 Model","volume":"10","author":"Van de Sande","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114746_b0755","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0760","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.hrthm.2015.10.027","article-title":"Beta-blockers in the treatment of catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"van der Werf","year":"2016","journal-title":"Heart rhythm"},{"issue":"2","key":"10.1016\/j.bcp.2021.114746_b0765","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hrthm.2015.09.027","article-title":"Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of beta-blockade","volume":"13","author":"Padfield","year":"2016","journal-title":"Heart rhythm"},{"issue":"92","key":"10.1016\/j.bcp.2021.114746_b0770","article-title":"CPVT: Arrhythmogenesis, Therapeutic Management, and Future Perspectives. A Brief Review of the Literature","volume":"6","author":"Baltogiannis","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.bcp.2021.114746_b0775","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.118.038514","article-title":"Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca(2+)\/Calmodulin-Dependent Kinase II","volume":"140","author":"Bezzerides","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bcp.2021.114746_b0780","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.hrthm.2005.07.025","article-title":"Functional assessment of compound mutations in the KCNQ1 and KCNH2 genes associated with long QT syndrome","volume":"2","author":"Grunnet","year":"2005","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.bcp.2021.114746_b0785","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/CIRCULATIONAHA.105.549071","article-title":"KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome","volume":"112","author":"Crotti","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bcp.2021.114746_b0790","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1046\/j.1540-8167.2001.01223.x","article-title":"Evidence for a single nucleotide polymorphism in the KCNQ1 potassium channel that underlies susceptibility to life-threatening arrhythmias","volume":"12","author":"Kubota","year":"2001","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0795","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCGENETICS.110.957696","article-title":"Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry","volume":"4","author":"Barajas-Martinez","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"issue":"5","key":"10.1016\/j.bcp.2021.114746_b0800","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.hrthm.2014.02.015","article-title":"KCNJ2 mutation causes an adrenergic-dependent rectification abnormality with calcium sensitivity and ventricular arrhythmia","volume":"11","author":"Kalscheur","year":"2014","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0805","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1172\/JCI31080","article-title":"Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia","volume":"117","author":"Song","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.bcp.2021.114746_b0810","first-page":"1864","article-title":"Methods for in vitro functional analysis of iPSC derived cardiomyocytes -Special focus on analyzing the mechanical beating behavior","volume":"1863","author":"Eeva","year":"2016","journal-title":"Bba-Mol Cell Res"},{"key":"10.1016\/j.bcp.2021.114746_b0815","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1875397301206010087","article-title":"A comparison of the performance and application differences between manual and automated patch-clamp techniques","volume":"6","author":"Yajuan","year":"2012","journal-title":"Curr Chem Genomics"},{"key":"10.1016\/j.bcp.2021.114746_b0820","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/B978-0-12-420138-5.00020-3","article-title":"High-resolution traction force microscopy","volume":"123","author":"Plotnikov","year":"2014","journal-title":"Methods Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114746_b0825","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ejcn.2016.265","article-title":"Limitations and requirements for measuring metabolic rates: a mini review","volume":"71","author":"Lighton","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.bcp.2021.114746_b0830","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061866","article-title":"Genetic Variants as Sudden-Death Risk Markers in Inherited Arrhythmogenic Syndromes: Personalized Genetic Interpretation","volume":"9","author":"Campuzano","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.bcp.2021.114746_b0835","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.hlc.2018.09.007","article-title":"Channelopathies That Lead to Sudden Cardiac Death: Clinicaland Genetic Aspects","volume":"28","author":"Skinner","year":"2019","journal-title":"Heart Lung Circ"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:34:51Z","timestamp":1757770491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221003622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":167,"alternative-id":["S0006295221003622"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114746","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling genetic cardiac channelopathies using induced pluripotent stem cells \u2013 Status quo from an electrophysiological perspective","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114746"}}